Family · Pharmaceutical analytical standards
Desloratadine
A second-generation H1 antihistamine, patented in 1984 and first marketed in Europe in 2001, used for allergic rhinitis and chronic urticaria: it does not usually cause drowsiness because it barely crosses the blood-brain barrier. This family brings together pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It is the main active metabolite of loratadine, developed as a medicine in its own right: it stays in the body a long time, with a half-life of about 27 hours.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
